|
Market Closed -
NYSE
16:00:03 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 118.28 USD | -2.48% |
|
-0.35% | +47.57% |
| 10-09 | Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating | MT |
| 10-08 | CSL to Transition US Plasma Centers to Haemonetics' Latest Plasmapheresis Platform | MT |
| Market Cap | 5.38B 4.78B 4.43B 4.03B 7.61B 511B 7.73B 53.29B 20.9B 267B 20.2B 19.77B 850B | P/E 2027 * |
29.8x | P/E 2028 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.04B 5.37B 4.98B 4.53B 8.55B 574B 8.69B 59.85B 23.47B 299B 22.68B 22.2B 954B | EV / Sales 2027 * |
4.27x | EV / Sales 2028 * | 3.82x |
| Free-Float |
98.74% | Yield 2027 * |
0.85% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Boerse Muenchen
| HAZ | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Tradegate
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | -2.48% | ||
| 1 week | -0.35% | ||
| Current month | +12.33% | ||
| 1 month | +11.33% | ||
| 3 months | +50.68% | ||
| 6 months | +96.77% | ||
| Current year | +47.57% |
| 1 week | 118.19 |  | 123.77 |
| 1 month | 101.32 | | 123.77 |
| Current year | 51 | | 123.77 |
| 1 year | 48.98 | | 123.77 |
| 3 years | 47.32 | | 123.77 |
| 5 years | 43.5 | | 123.77 |
| 10 years | 32.76 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2016-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 2022-04-10 |
Frank Chan
COO | Chief Operating Officer | 56 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 2005-12-31 |
| Director/Board Member | 62 | 2016-05-15 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 2017-10-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.48% | -0.35% | +137.65% | +31.31% | 5.38B | |
| +0.20% | +5.31% | -17.82% | +13.79% | 181B | |
| -0.73% | +7.09% | -0.31% | +32.06% | 116B | |
| +0.49% | +6.25% | -20.20% | +11.58% | 113B | |
| +3.83% | +5.50% | -44.18% | -6.77% | 79.83B | |
| -0.14% | +5.27% | +6.74% | +82.45% | 65.06B | |
| +2.79% | +2.37% | +15.93% | +68.64% | 54.35B | |
| -1.04% | +4.35% | +3.50% | -26.18% | 52.23B | |
| +2.41% | +8.18% | -12.08% | +30.45% | 44.15B | |
| -1.90% | +2.29% | +29.72% | +8.98% | 32.47B | |
| Average | +0.42% | +4.91% | +9.90% | +24.63% | 74.4B | |
| Weighted average by Cap. | +0.60% | +5.56% | -8.63% | +22.20% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.26B 1.17B 1.06B 2B 134B 2.04B 14.03B 5.5B 70.17B 5.32B 5.2B 224B | 1.5B 1.33B 1.23B 1.12B 2.12B 142B 2.15B 14.81B 5.81B 74.06B 5.61B 5.49B 236B |
| Net income | 177M 158M 146M 133M 251M 16.84B 255M 1.76B 689M 8.79B 666M 652M 28.01B | 207M 184M 171M 155M 293M 19.67B 298M 2.05B 805M 10.26B 778M 761M 32.72B |
| Net Debt | 662M 588M 545M 496M 936M 62.83B 951M 6.56B 2.57B 32.79B 2.48B 2.43B 105B | 327M 291M 270M 245M 463M 31.05B 470M 3.24B 1.27B 16.2B 1.23B 1.2B 51.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | US$118.28 | -2.48% | 471,521 |
| 26-10-15 | US$121.29 | +0.15% | 747,647 |
| 26-10-14 | US$121.11 | -0.50% | 592,144 |
| 26-10-13 | US$121.72 | -0.28% | 829,194 |
| 26-10-12 | US$122.06 | +2.84% | 895,092 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
